Prof. Mohammad Amjad Kamal, Australia joined Indo Global Journal of Pharmaceutical Sciences as Associate Editor

I am very pleased to inform all my readers, authors and editorial board members, that Prof. Mohammad Amjad Kamal ( King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia; Enzymoics, 7 Peterlee Place, Hebersham, NSW 2770, Australia and Novel Global Community Educational Foundation (NGCEF), Australia) has joined Indo Global Journal of Pharmaceutical Sciences as Associate Editor (https://www.iglobaljournal.com/editorial-board/). Its a Congratulations Moment for Journal.

Dr. Mohammad Amjad Kamal is a Distinguished Adjunct Professor at the King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia, where he was full Professor from March 2011 to March 2013. He is leading a highly productive global collaborative research team based from Novel Global Community Educational Foundation (NGCEF). Dr. Kamal’s biochemical research in the field of Alzheimer’s disease, Type 2 diabetes and leukemia has culminated in more than 320 publications in internationally respected journals, and 65 abstracts at international conferences.

The daily dose of the drug shouldn’t exceed 5 mg. The long-term use of Ambien (or any other sleeping pills) it is not recommended. The duration of treatment should be as short as possible: from several days to four weeks, including a period of dose reduction. Other recomendation for Ambien (Zolpidem) on website https://holisticdental.org/ambien-treat-insomnia/.

He is serving as external examiner for PhD thesis evaluation of various universities and as an EiC/regional/editorial member/guest editor of several reputed scientific journals – this is undertaken on an honorable basis, and includes the following:

1. Seminars in Cancer Biology
2. Journal of Medicinal Chemistry
3. Current Drug Metabolism
4. Current Pharmaceutical Design
5. Current Alzheimer Research
6. Neuroscience
7. Current Medicinal Chemistry
8. Current Topics in Medicinal Chemistry
9. CNS & Neurological Disorders-Drug Targets
10. BMC Neuroscience
11. Neural Plasticity
12. Frontiers in Aging Neuroscience
13. Oxidative Medicine and Cellular Longevity
14. Journal of Diabetes Research
15. Protein & Peptide Letters
16. Evidence-Based Complementary and Alternative Medicine
17. Metabolic & Immune Disorders – Drug Targets
18. Medicinal Chemistry
19. Pharmacognosy Magazine
20. Saudi Journal of Biological Sciences
21. Current Psychopharmacology
22. Molecular and Genetic Medicine
23. Journal of Neurological Disorders
24. Enzyme Engineering
25. Recent Patents on Nanomedicine
26. Journal of Advance Health Sciences
27. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy journal
28. Journal of Neuroprotection and Neuroregeneration
29. Drug Designing
30. Research Journal of Endocrinology and Metabolism
31. Journal of Medical Disorders
32. Journal of Molecular Biology and Techniques
33. The Open Biochemistry Journal
34. Current Aging Science
35. Jacobs Journal of Drug Metabolism and Toxicology
36. International Archives of Endocrinology Clinical Research
37. Journal of Neurology and Psychology
38. Enliven: Journal of Genetics, Molecular and Cellular Biology
39. Enliven: Neurology and Neurotechnology
40. Enliven: Pharmacovigilance and Drug Safety
41. Sydney Journal of Medical Sciences

I would like to personally thank Prof. Kamal for considering my request and joining our journal.

Regards

Rajeev K Singla

Founder and Editor-in-Chief